Tigecycline: Clinical Trials

62 trials of Tigecycline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 6 unknown, 5 withdrawn, 4 not yet recruiting. 20 Phase 3, 12 Phase 4, 8 Phase 2, 7 Not applicable, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 320Completed 13, Withdrawn 4, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 412Completed 8, Unknown 2, Active not recruiting 1, Terminated 1
Phase 28Completed 3, Not yet recruiting 2, Recruiting 1, Terminated 1, Withdrawn 1
Not applicable7Completed 4, Recruiting 1, Unknown 1, Withdrawn 1
Phase 15Completed 5
Early Phase 11Unknown 1

Follow Tigecycline: new trials by email Literature Review of Tigecycline trials Research Report on Tigecycline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation
Ceftazidime - Avibactam ( CAZ-AVI), Meropenem-Vaborbactam, Imipenem+Relebactam - Liver Transplant, Carbapenem-resistant Enterobacterales
Phase 3Not yet recruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1682026-10-012026-08-12
Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria
"Imipenem/cilastatin" and "Tigecycline", "colistin" and "meropenem" - MDR Bacteria
Phase 2Not yet recruitingAin Shams University602026-04-012026-04-13
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
Colistimethate Sodium, Tigecycline - Infection in ICU
Phase 4Active not recruitingBeni-Suef University1322024-12-012025-03-25
Comparing Tigecycline Vs. Colistimethate in CNS Infections
Tigecycline (Tygacil), Colistimethate sodium (CMS) - Central Nervous System Infections
Not yet recruitingAin Shams University702024-12-012024-11-25
Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital
chest x ray, chest X ray, Tigecycline (Tygacil) - Identify the Predictors of Antibiotic Resistance
CompletedMohamed Sabry502024-10-012024-12-27
Comparing Oral Versus Parenteral Antimicrobial Therapy
Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection
Phase 4TerminatedWest Virginia University942023-08-042025-08-26
Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients
Saline, Tigecycline and heparin, Taurolidine-citrate-heparin - Taurolidine, Lock Solution
Not applicableCompletedTanta University1202023-05-012026-01-26
Clinical Effectiveness of Tigecycline for Scrub Typhus.
doxycycline, Tigecycline (Tygacil) - Scrub Typhus
Not applicableCompletedJin Soo Lee272022-11-192026-08-11
Antibiotic Therapy for Infectious Diseases
Tigecycline - Infectious Disease
UnknownShandong University3002021-06-012021-06-24
Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center
extended meropenem infusion in combination with other options such as Polymyxin, Tigecycline, Ertapenem, or Amikacin., two β-lactam antibiotics plus a single non-β-lactam antibiotic, Control group received standard therapy - Ventilation Acquired Pneumonia
Phase 3CompletedBeni-Suef University642021-01-012024-12-18
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
Tigecycline 50 MG, Placebo - Microbial Disease
Not applicableRecruitingZealand University Hospital282020-05-012024-01-30
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis)
Phase 2 / Phase 3RecruitingThe University of Queensland3002020-03-022026-05-11
A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.
Imipenem, Tigecycline, GMCSF - Spontaneous Bacterial Peritonitis
Not applicableUnknownInstitute of Liver and Biliary Sciences, India902019-12-202021-02-16
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
Delafloxacin, Vancomycin, Linezolid - Surgical Site Infection
Phase 3TerminatedMenarini Group2682019-09-252022-02-02
Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae
Colistin, Meropenem, Tigecycline - Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae
Phase 4UnknownAl-Azhar University602019-09-212020-07-29
The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
Fosfomycin, Tigecycline, Polymyxin B - Antibiotic Resistant Infection
Early Phase 1UnknownShanghai 10th People's Hospital802019-01-012019-05-15
Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)
Tigecycline - Bacterial Infection, Critically Ill
UnknownZhujiang Hospital202016-08-012016-10-13
The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin, Appendectomy - Appendicitis
Not applicableCompletedUniversity of Washington15522016-05-012023-05-06
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
plazomicin, colistin, meropenem - Bloodstream Infections (BSI) Due to CRE, Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE
Phase 3CompletedAchaogen, Inc.692014-09-162018-10-16

Showing 20 of 62. Sign in to see all of them.

Conditions studied

Infections (9)  ·  Bacterial Infections (8)  ·  Cross Infection (5)  ·  Intraabdominal Infections (5)  ·  Pneumonia, Bacterial (5)  ·  Skin Diseases, Infectious (5)  ·  Cellulitis (4)  ·  Peritonitis (4)  ·  Pneumonia (4)  ·  Skin Diseases, Bacterial (4)  ·  Abdominal Abscess (3)  ·  Appendicitis (3)  ·  Community-Acquired Infections (3)  ·  Cholecystitis (2)  ·  Diverticulitis (2)

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer (22)  ·  Pfizer (9)  ·  Ain Shams University (2)  ·  Beni-Suef University (2)  ·  The University of Queensland (2)  ·  University of California, San Diego (2)  ·  Achaogen, Inc. (1)  ·  Al-Azhar University (1)  ·  CPL Associates (1)  ·  Federico II University (1)  ·  Gary E. Stein, Pharm.D. (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  Jin Soo Lee (1)  ·  Mahidol University (1)

Countries

United States (19)  ·  Taiwan (8)  ·  China (7)  ·  Egypt (6)  ·  Canada (5)  ·  Italy (5)  ·  South Korea (5)  ·  Australia (4)  ·  Denmark (4)  ·  Germany (4)  ·  South Africa (4)  ·  Argentina (3)  ·  Brazil (3)  ·  Chile (3)  ·  France (3)

Top investigators

Aaron Schimmer, MD (1)  ·  Arif R. Sarwari, MD, MSc, MBA (1)  ·  David A Talan, MD (1)  ·  David R Flum, MD, MPH (1)  ·  Dennis G Maki, M.D. (1)  ·  Gary Stein, PharmD (1)  ·  Guglielmo Borgia (1)  ·  Jeanne Breen, MD (1)  ·  Jin-Soo Lee, MD., PhD. (1)  ·  Joy J. Juskowich, MD (1)  ·  Li Hua, master (1)

Results publications

PMID 18508226, PMID 19036670, PMID 23772042, PMID 23772045, PMID 23772047, PMID 24633206, PMID 16236177, PMID 18436554, PMID 18643743, PMID 18990531, PMID 19036671, PMID 19036672, PMID 19740418, PMID 20663130, PMID 20670293, PMID 22249106, PMID 22439781, PMID 22812672, PMID 23145952, PMID 23357775, PMID 23403419, PMID 23883872, PMID 24155157, PMID 24439136, PMID 25448332, PMID 28970161, PMID 29146633, PMID 30584308, PMID 31254273, PMID 32716292, PMID 35046672, PMID 35363884, PMID 35612859, PMID 35796152, PMID 35815898, PMID 36197656, PMID 37379001, PMID 40908975, PMID 41419216, PMID 42750051

NIH funding

2018 (1), 2025 (1)